Additional information Peer review information Nature Metabolism thanks Dominique Langin and the other, anonymous reviewers for their contribution to the peer review of this work
The STEP 4 withdrawal trial showed that most participants regained approximately two-thirds of lost weight within one year of discontinuation, confirming that semaglutide treats obesity chronically rather than curing it
For purity verification standards to assess before reconstituting, see Third-Party Testing and Purity Standards for Research-Grade TB-500 and BPC-157
It is not intended to diagnose, treat, cure or prevent any disease, and no therapeutic, weight-management, performance or physique claims are made or implied
Analytical data Specifications, verified